Reunion of the DART team at the #SWOG Early Therapeutics & Rare Cancer Committee meeting in San Francisco! Thanks for the picture Razelle Kurzrock, MD!

SWOG ETRC giants! Marcia Horn – a phenomenal patient advocate, Megan Othus – an outstanding lead statistician, and Razelle Kurzrock, MD – the best chair ever! A true team effort! The Hope Foundation for Cancer Research

S2012: The 1st-line EP +/- atezolizumab RCT in extra-pulmonary neuroendocrine carcinoma is accruing well! Please keep this important trial on your radar from our ERTC committee. Kudos to Dr. David Zhen for his leadership! SWOG Cancer Research Network The Hope Foundation for Cancer Research OncoAlert

The SWOG team in action—making things happen!

Teaming up to drive translational medicine forward in our SWOG Cancer Research Network trials—grateful for the amazing collaboration with NCI CIMAC lead, Dr. Cara Haymaker from MD Anderson Cancer Center The Hope Foundation for Cancer Research OncoAlert NCICancerTrials

Proof-of-concept trial shows that real-time immune spatial transcriptomics can help identify which TNBC patients may benefit from immunotherapy alone—avoiding unnecessary chemo-immuno treatment. Incredible plenary talk by Dr. MarleenKokLab from The Netherlands Cancer Institute at #AACR25! OncoAlert AACR

Circulating B cells may be a stronger predictor of #immunotherapy response than TMB, PD-L1, TILs, or even TLS! At least in HNSCC. Fascinating talk by Dr. Eytan Ruppin, MD, PhD from National Cancer Institute at the SWOG Cancer Research Network Immunotherapy Committee meeting. The Hope Foundation for Cancer Research OncoAlert

Absolutely loved the passionate and inspiring conversations at the SWOG ETRC Committee working dinner! Energized by this brilliant and dedicated group. Razelle Kurzrock, MD SWOG Cancer Research Network The Hope Foundation for Cancer Research Krishna Soujanya Gunturu MD Matthew Hadfield

Grateful to be part of the ever-brilliant SWOG Lung Committee. Today’s working group meeting brought sharp minds, great energy, and even a few laughs. Cheers to Jhanelle Gray MD for leading with such poise and purpose! SWOG Cancer Research Network The Hope Foundation for Cancer Research

Clinical trials are the key to bringing tomorrow’s treatments to patients today. It’s all about building the right infrastructure and fostering strong relationships. Thank you to Dr. Raymond Osarogiagbon, MBBS, FACP for an inspiring plenary at SWOG Cancer Research Network. The Hope Foundation for Cancer Research

We are stronger than cancer. We strive for authenticity, harmony, and resilience — values that guide us forward. “Walk in Beauty and Strength.” An inspiring message from ASCO President Dr. Robin Zion at #ASCO25.

AI is democratizing healthcare — giving clinicians more time with patients and making best care accessible to all. “Why not make best care the norm.” Inspiring words from Ruth Porat (Alphabet & Google President) at #ASCO25 ASCO.

“Never underestimate the power of encouragement.” Expanding access and improving care delivery must remain top priorities. We need to champion publicly funded clinical research — including programs like NCORP/SWOG Cancer Research Network An inspiring message from Dr. Dawn Hershman at #ASCO25. ASCO

A serum proteomics signature reflecting lung tissue damage can predict immunotherapy response in non-small cell lung cancer. Grateful for our incredible collaboration team! ASCO #ASCO25 OncoHost Lurie Cancer Center Northwestern Feinberg School of Medicine OncoAlert NM Pulmonary and Thoracic Surgery

A radiomics signature linked to tumor angiogenesis predicts response to multiple immunotherapy regimens in non-small cell lung cancer. Proud to collaborate with PictureHealth ! ASCO #ASCO25 Lurie Cancer Center Northwestern Feinberg School of Medicine NM Pulmonary and Thoracic Surgery OncoAlert

Honored to have chaired the pre-ASCO Precision Immuno-Oncology meeting with our Latin American medical oncology colleagues. Grateful for the lively, insightful discussions—challenging cases, valuable lessons, and great collaboration. NM Pulmonary and Thoracic Surgery Lurie Cancer Center Northwestern Feinberg School of Medicine

AI-powered assessment of tertiary lymphoid structures (TLS) from whole slide images (WSIs) appears to predict immunotherapy response, regardless of TIL score or treatment regimen. Excited to see our lung cancer TLS study from NU validated ASCO OncoAlert #ASCO25 Se-Hoon Lee

SACHI study: randomized phase 3 savolitinib plus osimertinib vs. SOC chemo post EGFR TKIs in EGFR mutated MET amplified (by FISH) NSCLC seems promising and tolerable. Presented by Dr. Shun Lu ASCO #ASCO25 OncoAlert Oncology at AstraZeneca

AI-driven radiomics doesn’t just predict how patients respond to immunotherapy; it can also flag immune-related pneumonitis. Huge thanks to Yuri Velichko and our awesome Northwestern Feinberg School of Medicine lab memembers for all the teamwork! NM Pulmonary and Thoracic Surgery Lurie Cancer Center OncoAlert mdpi.com/2077-0383/14/1…

This long-awaited study reveals that even within the same tumor, some cancer cell subclones are inherently better at evading the immune system. It provides the first direct functional proof of this hidden complexity in cancer. youtube.com/watch?v=arqD9f… Charles Swanton